Betel quid-associated cancer: Prevention strategies and targeted treatment

doi:10.1016/j.canlet.2020.02.030

IVPP-IR > 中科院古脊椎所（2000年以后）

	Betel quid-associated cancer: Prevention strategies and targeted treatment
	Ko, Albert Min-Shan 1; Lee, Chien-Hung 2,3; Ko, Ying-Chin 4,5
	2020-05-01
发表期刊	CANCER LETTERS
ISSN	0304-3835
卷号	477 期号:0 页码:60-69
摘要	Betel quid (BQ) and areca nut use are at risk of cancer. This review includes the latest evidence of carcinogenesis caused by BQ exposure, suggests possible prevention strategies. We conducted a systematic literature search in the PubMed and Web of Science databases to identify relevant articles published in the past 10 years according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Arecoline N-oxide, a metabolite of areca nut, is likely an initiator in carcinogenesis and is detoxified by N-acetylcysteine. Oral potentially malignant disorder and reactive oxygen species involved in carcinogenesis pathways may be treatable using antioxidants. Screening programs conducted by trained physicians are useful for identifying patients with early stages of oral cancer in high-risk groups. Anti-inflammatory medications may be used as chemopreventive agents in the disease-free stage after surgery. The association between survival and tumor somatic mutations in patients who chew BQ should be addressed in cancer studies. Current evidence on the natural course from BQ exposure to cancer occurrence and development provides information for developing primary, secondary, and tertiary prevention strategies against BQ-associated cancer at clinical or translational levels.
关键词	Detoxification Carcinogenesis Chemoprevention Arecoline N-Oxide Reactive oxygen species
DOI	10.1016/j.canlet.2020.02.030
关键词[WOS]	SQUAMOUS-CELL CARCINOMA ; ORAL SUBMUCOUS FIBROSIS ; POTENTIALLY MALIGNANT DISORDERS ; ARECOLINE N-OXIDE ; ARECA-CATECHU NUT ; ALCOHOL-CONSUMPTION ; TOBACCO SMOKING ; BUCCAL MUCOSA ; RISK ; SALIVA
收录类别	SCI
语种	英语
资助项目	Ministry of Science and Technology[MOST 106-2314-B-039-016-MY3] ; China Medical University Hospital[DMR 109-250]
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000525867900007
出版者	ELSEVIER IRELAND LTD
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.205/handle/311034/17322
专题	中科院古脊椎所（2000年以后）
通讯作者	Ko, Ying-Chin
作者单位	1.Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China 2.Kaohsiung Med Univ, Dept Publ Hlth & Res, Ctr Environm Med, Kaohsiung, Taiwan 3.Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan 4.China Med Univ, China Med Univ Hosp, Environm Omics Dis Res Ctr, Taichung, Taiwan 5.Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan
推荐引用方式 GB/T 7714	Ko, Albert Min-Shan,Lee, Chien-Hung,Ko, Ying-Chin. Betel quid-associated cancer: Prevention strategies and targeted treatment[J]. CANCER LETTERS,2020,477(0):60-69.
APA	Ko, Albert Min-Shan,Lee, Chien-Hung,&Ko, Ying-Chin.(2020).Betel quid-associated cancer: Prevention strategies and targeted treatment.CANCER LETTERS,477(0),60-69.
MLA	Ko, Albert Min-Shan,et al."Betel quid-associated cancer: Prevention strategies and targeted treatment".CANCER LETTERS 477.0(2020):60-69.

条目包含的文件		下载所有文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
Betel quid-associate（838KB）	期刊论文	作者接受稿	开放获取	CC BY-NC-SA	浏览下载